Ryan Preblick
Director of Finance/CFO en INDIVIOR PLC .
Fortuna: 1 M $ al 31/03/2024
Perfil
Ryan Preblick is currently the Chief Financial Officer & Executive Director at Indivior PLC since 2020.
He is also currently the Chief Financial Officer, Secretary & Treasurer at Opiant Pharmaceuticals, Inc. Mr. Preblick completed his undergraduate degree at The Pennsylvania State University and holds an MBA from the University of Richmond.
Participaciones conocidas en empresas públicas
Empresa | Fecha | Número de acciones | Valoración | Fecha de valoración |
---|---|---|---|---|
INDIVIOR PLC
0.05% | 15/03/2024 | 68 386 ( 0.05% ) | 1 M $ | 31/03/2024 |
Cargos activos de Ryan Preblick
Empresas | Cargo | Inicio |
---|---|---|
INDIVIOR PLC | Director of Finance/CFO | 29/06/2020 |
OPIANT PHARMACEUTICALS, INC. | Director of Finance/CFO | - |
Formación de Ryan Preblick.
The Pennsylvania State University | Undergraduate Degree |
University of Richmond | Masters Business Admin |
Experiencias
Funciones ocupadas
Activas
Inactivas
Empresas cotizadas
Empresas privadas
Relaciones
Relaciones de 1er grado
Empresas vinculadas al 1er grado
Hombre
Mujer
Administradores
Ejecutivos
Empresas relacionadas
Empresas cotizadas | 1 |
---|---|
INDIVIOR PLC | Health Technology |
Empresas privadas | 1 |
---|---|
Opiant Pharmaceuticals, Inc.
Opiant Pharmaceuticals, Inc. Pharmaceuticals: MajorHealth Technology Opiant Pharmaceuticals, Inc. is a pharmaceutical company, which engages in the development of pharmaceutical solutions for common addictions and related disorders. The firm focuses on developing treatment to reverse opioid overdoses, treatment for overweight and obese patients with binge eating disorder and treatment for patients with Bulimia Nervosa. Its principal product Naloxone is a medicine which is available through injection can reverse the overdose of prescription and illicit opioids. The company was founded on June 21, 2005 and is headquartered in Richmond, VA. | Health Technology |
- Bolsa de valores
- Insiders
- Ryan Preblick